Current Partnering’s comprehensive listing of terms used in business development.
When I use a word,’ Humpty Dumpty said in a rather scornful tone. ‘it means just what I choose it to mean – neither more nor less.’ Lewis Carroll, Through the Looking Glass
Do you want to add a new or update an existing glossary term? All accepted contributions will be acknowledged. Contribute now
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are the same because they are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies have monovalent affinity, in that they bind to the same epitope. Given almost any substance, it is possible to produce monoclonal antibodies that specifically [...]
Monoclonal antibody – a type of biological product with therapeutic potential.
The term used in the UK for an approval to market a medicinal product, granted by the Medicines Control Agency. Referred to as a Product Approval in the U.S.
Similar to that utilized in valuing a house – namely look at what similar companies are valued at or have sold for in the recent past. The difficulty lies in identifying public companies that are sufficiently comparable to the subject company for this purpose. Often, one can utilize a quick short-hand market approach via a [...]
To enable a manager or group of managers from outside a company to buy into it.
To enable the current operating management and investors to acquire or to purchase a significant shareholding in the product line or business they manage. MBOs range from the acquisition of relatively small formerly family owned businesses to £100 million plus buy-outs. The amounts concerned tend to be larger than other types of financing, as they [...]
